Company profile: H2 Pharma
1.1 - Company Overview
Company description
- Provider of non-sterile liquid pharmaceutical specialties, producing mouthwash, syrup, and oral solutions while controlling the entire drug value chain from sourcing active ingredients to production. Offers pharmaceutical development under strict GMP with advanced equipment, fully automated dedicated production lines to prevent cross-contamination, and pharmacovigilance and medical information services.
Products and services
- Non-Sterile Liquid Pharmaceutical Specialties: H3 Pharma produces non-sterile mouthwash, syrup, and oral solutions, controlling the full drug value chain from active-ingredient sourcing to production, ensuring quality and on-time delivery
- Automated Production Lines: H3 Pharma operates fully automated lines for non-sterile liquids that prevent cross-contamination via dedicated lines and sustain high production flow, achieving productivity and yields rarely equalled
- Pharmaceutical Development: H3 Pharma architects GMP-integrated development using advanced technological equipment to guarantee quality and regulatory compliance for non-sterile liquid pharmaceuticals
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to H2 Pharma
Gelpell
HQ: Switzerland
Website
- Description: Provider of manufacturing for food supplements and nutrients, offering soft gelatin capsules for oily and semi-solid preparations; Gelpell® beads for slow, even release and improved bioavailability; hard capsules with powders or Gelpell® beads; plant-based pea-starch soft capsules; blister packaging compliant with pharmaceutical standards; and bulk product supply.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gelpell company profile →
INW
HQ: United States
Website
- Description: Provider of manufacturing services for dietary supplements, sports nutrition, cosmetics, tablets, and other wellness products, producing powders (meal replacements, plant-based protein, vitamin herbal), capsules and tablets (amino acids, delayed release, multivitamins), soft gels (fish oil, omega-3), nutritional gels, functional beverages (energy shots, aloe vera), and bars.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full INW company profile →
Pharmaceutics International
HQ: United States
Website
- Description: Provider of science-driven contract development and manufacturing services, offering formulation development and clinical trial manufacturing for drugs and biologics; solubility/bioavailability enhancement; lyophilization formulation and cycle development with GMP scale-up; fill-finish development and aseptic fill-finish for vials, syringes, and cartridges; and ready-to-use 3mL cartridges for consistent delivery of high-viscosity, high concentration injectables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmaceutics International company profile →
Quotient Sciences
HQ: United Kingdom
Website
- Description: Provider of formulation development, clinical pharmacology, and clinical-to-commercial manufacturing. Services span preformulation; small-batch supply to accelerate POC; 14-day make-test cycles in humans; process development and scale-up through Phase II/III; commercial manufacturing for ANDA/NDA/MAA/Japanese NDA; and Translational Pharmaceutics integrating formulation, adaptive GMP manufacturing, and clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quotient Sciences company profile →
Rhenovia
HQ: France
Website
- Description: Provider of applications of biosimulation rooted in neuroscience and nervous system modeling, from a French biotechnology company founded in 2007 by managers from large pharmaceutical companies and world experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rhenovia company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for H2 Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to H2 Pharma
2.2 - Growth funds investing in similar companies to H2 Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for H2 Pharma
4.2 - Public trading comparable groups for H2 Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →